Strategy

Vision

To build a global biopharmaceutical leader, based on unique blending of innovation, entrepreneurship and proven experience, bring new medicines to specialists to treat patients suffering from severe diseases.

Strategy

We are determined to become the next generation biopharma leader and to enable families with severe diseases to lead normal, everyday lives. This is underpinned by a clear and pragmatic strategy.

This involves

• Focusing on severe diseases in three therapeutic areas: Central Nervous System, Inflammation and Oncology
• Combining biology and chemistry to make major breakthroughs
• Partnering with leaders in the pharmaceutical industry
• Leveraging our global scale and intellectual capital

Key Strengths

• Strong and promising late stage development pipeline
• Leader in fields of epilepsy, allergy and antibody research
• Proven productivity in research with several promising drugs in pipeline
• Global presence in over 40 countries with proven marketing expertise
• Strong partnerships and experienced management